Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Anti-MIF nanobody therapy potentiates anti-PD1 treatment by enhancing anti-tumor immunity in a pre-clinical colorectal cancer model
Mora Barthelmess, R., Lage Marques, B. (Contributor), Zivalj, M. (Contributor), Van Craenenbroeck, J. (Contributor), Jumapili, A. N. (Contributor), Vincke, C. (Contributor), Hadadi, E. (Contributor), Arnouk, S. (Contributor), Stijlemans, B. & Van Ginderachter, J., 2025, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
Anti-MIF Nbs, a novel tool
Mora Barthelmess, R., Zivalj, M. (Contributor), Lage Marques, B. (Contributor), Van Craenenbroeck, J. (Contributor), Jumapili, A. N. (Contributor), Vincke, C. (Contributor), Arnouk, S. (Contributor), Hadadi, E. (Contributor), Stijlemans, B. & Van Ginderachter, J., 26 Apr 2025.Research output: Unpublished contribution to conference › Poster
-
Characterization and validation of Lipocalin-2-targeting Nanobodies with application potential across various disease models
Zivalj, M., Vincke, C. (Contributor), Sánchez-Bayuela, T. (Contributor), Romao, E. (Contributor), Destrijcker, R. (Contributor), Ahmed, D. T. A. A. (Contributor), Mehmeti, N. (Contributor), Gupta, M. S. (Contributor), Schoonooghe, S. (Contributor), Hassanzadeh Ghassabeh, G. (Contributor), Arnouk, S. (Contributor), Raes, G. (Contributor), Jaisser, F. (Contributor), Sterckx, Y.G.-J. (Contributor), Van Ginderachter, J. (Contributor) & Stijlemans, B., 2025.Research output: Unpublished contribution to conference › Poster
-
GPNMB+ Tumor-Associated Macrophages Exhibit Elevated Lipid Metabolism and Immunosuppressive Phenotype in NSCLC
Van Craenenbroeck, J., Arnouk, S. (Contributor), Raes, G. (Contributor), Swinnen, J. V. (Contributor), Van Ginderachter, J., Mora Barthelmess, R. (Contributor), Jumapili, A. N. (Contributor) & Zivalj, M. (Contributor), Sept 2025.Research output: Unpublished contribution to conference › Poster
-
GPNMB+ Tumor-Associated Macrophages Exhibit Elevated Lipid Metabolism and Immunosuppressive Phenotype in NSCLC
Van Craenenbroeck, J., Arnouk, S. (Contributor), Raes, G. (Contributor), Swinnen, J. V. (Contributor), Van Ginderachter, J., Mora Barthelmess, R. (Contributor), Jumapili, A. N. (Contributor) & Zivalj, M. (Contributor), Sept 2025.Research output: Unpublished contribution to conference › Poster
Datasets
-
Dataset "Infection history imprints prolonged changes to the Kupffer cell epigenome, transcriptome and function of Kupffer cells"
Van Ginderachter, J. (Creator), Musrati, M. (Creator), Kancheva, D. (Creator), Stijlemans, B. (Creator), Azouz , A. (Creator), Mesbahi, S. (Creator), Hadadi, E. (Creator), Lebegge, E. (Creator), Ali, L. (Creator), De Vlaminck, K. (Creator), Scheyltjens, I. (Creator), Vandamme, N. (Creator), Zivalj, M. (Creator), Assaf, N. (Creator), Elkrim, Y. (Creator), Ahmidi, I. (Creator), Huart, C. (Creator), Lamkanfi, M. (Creator), Guilliams, M. (Creator), De Baetselier, P. (Creator), Goriely, S. (Creator) & Movahedi, K. (Creator), NCBI Gene Expression Omnibus, 12 Aug 2024
Dataset
-
GPNMB+ Tumor-Associated Macrophages Exhibit Elevated Lipid Metabolism and Immunosuppressive Phenotype in NSCLC
Van Craenenbroeck, J. (Speaker), Arnouk, S. (Contributor), Raes, G. (Contributor), Van Ginderachter, J. (Contributor), Swinnen, J. V. (Contributor), Mora Barthelmess, R. (Contributor), Jumapili, A. N. (Contributor) & Zivalj, M. (Speaker)
Oct 2025Activity: Talk or presentation › Talk or presentation at a conference
-
GPNMB+ Tumor-Associated Macrophages Exhibit Elevated Lipid Metabolism and Immunosuppressive Phenotype in NSCLC
Van Craenenbroeck, J. (Speaker), Arnouk, S. (Contributor), Raes, G. (Contributor), Van Ginderachter, J. (Contributor), Swinnen, J. V. (Contributor), Mora Barthelmess, R. (Contributor), Jumapili, A. N. (Contributor) & Zivalj, M. (Speaker)
Oct 2025Activity: Talk or presentation › Talk or presentation at a conference
-
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
Clappaert, E. (Speaker), Kancheva, D. (Contributor), Brughmans, J. (Contributor), Debraekeleer, A. (Contributor), Bardet, P. (Contributor), Elkrim, Y. (Contributor), Lacroix, D. (Contributor), Zivalj, M. (Contributor), Hamouda, A. E. I. (Contributor), Van Ginderachter, J. (Contributor), Deschoemaeker, S. (Contributor) & Laoui, D. (Contributor)
16 Oct 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Flt3L therapy induces a Treg-promoting cDC1 state in triple-negative breast cancer
Clappaert, E. (Speaker), Kancheva, D. (Contributor), Brughmans, J. (Contributor), Debraekeleer, A. (Contributor), Bardet, P. (Contributor), Elkrim, Y. (Contributor), Lacroix, D. (Contributor), Zivalj, M. (Contributor), Hamouda, A. E. I. (Contributor), Van Ginderachter, J. (Contributor), Deschoemaeker, S. (Contributor) & Laoui, D. (Contributor)
8 Jun 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
Thesis
-
Validation of anti-Lipocalin-2 Nanobodies (anti-Lcn-2 Nbs) as anti-tumor treatment
Živalj, M. ((PhD) Student), Van Ginderachter, J. (Promotor), Raes, G. (Promotor) & Stijlemans, B. (Co-promotor), 4 Sept 2020Student thesis: Master's Thesis
-
Validation of anti-Lipocalin-2 Nanobodies (anti-Lcn-2 Nbs) as anti-tumor treatment
Stijlemans, B. (Co-promotor), Van Ginderachter, J. (Promotor), Raes, G. (Promotor) & Zivalj, M. ((PhD) Student), 4 Sept 2020Student thesis: Master's Thesis